Patients with cancers that are driven by certain mutations occurring in response to DNA damage can be safely treated with two drugs, olaparib and adavosertib, if they are given in sequence rather than concurrently.
from Medical Xpress - latest medical and health news stories https://ift.tt/g59MlDT
